These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15508729)

  • 1. [Molecular pathogenesis of mycobacterial diseases].
    Kobayashi K
    Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):263-70. PubMed ID: 15508729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of mycobacterial glycolipids with host cells.
    Vergne I; Daffé M
    Front Biosci; 1998 Aug; 3():d865-76. PubMed ID: 9693156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of pathogenicity in mycobacteria.
    Rastogi N; David HL
    Biochimie; 1988 Aug; 70(8):1101-20. PubMed ID: 3147701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
    Källenius G; Correia-Neves M; Buteme H; Hamasur B; Svenson SB
    Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterial Pathogenomics and Evolution.
    Bottai D; Stinear TP; Supply P; Brosch R
    Microbiol Spectr; 2014 Feb; 2(1):MGM2-0025-2013. PubMed ID: 26082120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of Mycobacterial Lipids by Immune Receptors.
    Ishikawa E; Mori D; Yamasaki S
    Trends Immunol; 2017 Jan; 38(1):66-76. PubMed ID: 27889398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The 72nd Annual Meeting Education Lecture. Cord factor].
    Yano I
    Kekkaku; 1998 Jan; 73(1):37-42. PubMed ID: 9494342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemistry and bioactivities of mycobacterial components].
    Yano I
    Nihon Rinsho; 1998 Dec; 56(12):3008-16. PubMed ID: 9883601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression.
    Guenin-Macé L; Siméone R; Demangel C
    Transbound Emerg Dis; 2009 Aug; 56(6-7):255-68. PubMed ID: 19486312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Playing hide-and-seek with host macrophages through the use of mycobacterial cell envelope phthiocerol dimycocerosates and phenolic glycolipids.
    Arbues A; Lugo-Villarino G; Neyrolles O; Guilhot C; Astarie-Dequeker C
    Front Cell Infect Microbiol; 2014; 4():173. PubMed ID: 25538905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial trehalose 6,6'-dimycolate preferentially induces type 1 helper T cell responses through signal transducer and activator of transcription 4 protein.
    Oiso R; Fujiwara N; Yamagami H; Maeda S; Matsumoto S; Nakamura S; Oshitani N; Matsumoto T; Arakawa T; Kobayashi K
    Microb Pathog; 2005; 39(1-2):35-43. PubMed ID: 15967629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carbohydrate- and lipid-containing cell wall of mycobacteria, phenolic glycolipids: structure and immunological properties.
    Puzo G
    Crit Rev Microbiol; 1990; 17(4):305-27. PubMed ID: 2206395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic and immunosuppressive properties of mycobacterial phenolic glycolipids.
    Oldenburg R; Demangel C
    Biochimie; 2017 Oct; 141():3-8. PubMed ID: 28322927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
    Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
    Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells.
    Schaible UE; Hagens K; Fischer K; Collins HL; Kaufmann SH
    J Immunol; 2000 May; 164(9):4843-52. PubMed ID: 10779793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective autophagy receptors Optineurin and p62 are both required for zebrafish host resistance to mycobacterial infection.
    Zhang R; Varela M; Vallentgoed W; Forn-Cuni G; van der Vaart M; Meijer AH
    PLoS Pathog; 2019 Feb; 15(2):e1007329. PubMed ID: 30818338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterial infection of macrophages results in membrane-permeable phagosomes.
    Teitelbaum R; Cammer M; Maitland ML; Freitag NE; Condeelis J; Bloom BR
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15190-5. PubMed ID: 10611360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.